ANNA LONGURYAN: Open Payments
NPI 1336769728 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$156 in 7 payments from 3 companies in 2025. Trend: 2023 $385 · 2024 $398 · 2025 $156
Food & beverage: $156
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $79 |
| Amgen Inc. | 3 | $59 |
| Eisai Inc. | 1 | $18 |
Products named: TRELEGY ELLIPTA, OTEZLA, Leqembi.
Industry payments across CA — which companies pay providers there.
